On the 10th of December 2021, ContextVision AB held an Extraordinary General Meeting in Stockholm.
- The Board's proposal for a resolution on dividend of all shares in the Company’s wholly-owned subsidiary INIFY Laboratories AB containing the line of business Digital Pathology to the shareholders of ContextVision AB, was approved.
- No other matters were processed at the meeting.
Minutes of the meeting are attached hereto and will also be available on ContextVisions’ website www.contextvision.com
###
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.